A Review on the Impact of Body Mass Index on Outcomes in Pediatric Leukemia

References

• Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103. doi:10.3322/caac.2121924488779
   PubMed Web of Science ®Google Scholar
• Rogers PC, Meacham LR, Oeffinger KC, Henry DW, Lange BJ. Obesity in pediatric oncology. Pediatr Blood Cancer. 2005;45(7):881–891. doi:10.1002/pbc.2045116035086
   PubMed Web of Science ®Google Scholar
• Pietrobelli A, Faith MS, Allison DB, Gallagher D, Chiumello G, Heymsfield SB. Body mass index as a measure of adiposity among children and adolescents: a validation study. J Pediatr. 1998;132(2):204–210. doi:10.1016/s0022-3476(98)70433-09506629
   PubMed Web of Science ®Google Scholar
• Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center For Health Statistics version. Pediatrics. 2002;109(1):45–60. doi:10.1542/peds.109.1.4511773541
   PubMed Web of Science ®Google Scholar
• Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol. 2016;34(35):4270–4276. doi:10.1200/JCO.2016.67.428327903155
   PubMed Web of Science ®Google Scholar
• Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet. 2000;39(3):215–231. doi:10.2165/00003088-200039030-0000411020136
   PubMed Web of Science ®Google Scholar
• Jain R, Chung SM, Jain L, et al. Implications of obesity for drug therapy: limitations and challenges. Clin Pharmacol Ther. 2011;90(1):77–89. doi:10.1038/clpt.2011.10421633345
   PubMed Web of Science ®Google Scholar
• Lange BJ, Gerbing RB, Feusner J, et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA. 2005;293(2):203–211. doi:10.1001/jama.293.2.20315644547
   PubMed Web of Science ®Google Scholar
• Butturini AM, Dorey FJ, Lange BJ, et al. Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2007;25(15):2063–2069. doi:10.1200/JCO.2006.07.779217513811
   PubMed Web of Science ®Google Scholar
• Saenz AM, Stapleton S, Hernandez RG, et al. Body mass index at pediatric leukemia diagnosis and the risks of relapse and mortality: findings from a single institution and meta-analysis. J Obes. 2018;2018:7048078. doi:10.1155/2018/704807830515322
   PubMed Web of Science ®Google Scholar
• Orgel E, Genkinger JM, Aggarwal D, Sung L, Nieder M, Ladas EJ. Association of body mass index and survival in pediatric leukemia: a meta-analysis. Am J Clin Nutr. 2016;103(3):808–817. doi:10.3945/ajcn.115.12458626864366
   PubMed Web of Science ®Google Scholar
• Amankwah EK, Saenz AM, Hale GA, Brown PA. Association between body mass index at diagnosis and pediatric leukemia mortality and relapse: a systematic review and meta-analysis. Leuk Lymphoma. 2016;57(5):1140–1148. doi:10.3109/10428194.2015.107681526453440
   PubMed Web of Science ®Google Scholar
• Popkin BM. The nutrition transition: an overview of world patterns of change. Nutr Rev. 2004;62(7):S140–143. doi:10.1111/j.1753-4887.2004.tb00084.x15387480
   PubMed Web of Science ®Google Scholar
• Hijiya N, Panetta JC, Zhou Y, et al. Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood. 2006;108(13):3997–4002. doi:10.1182/blood-2006-05-02441416917005
   PubMed Web of Science ®Google Scholar
• Baillargeon J, Langevin A-M, Lewis M, et al. Obesity and survival in a cohort of predominantly Hispanic children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2006;28(9):575–578. doi:10.1097/01.mph.0000212985.33941.d817006263
   PubMed Web of Science ®Google Scholar
• Niinimäki RA, Harila-Saari AH, Jartti AE, et al. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. J Clin Oncol. 2007;25(12):1498–1504. doi:10.1200/JCO.2006.06.253917442991
   PubMed Web of Science ®Google Scholar
• Gelelete CB, Pereira SH, Azevedo AMB, et al. Overweight as a prognostic factor in children with acute lymphoblastic leukemia. Obes Silver Spring Md. 2011;19(9):1908–1911. doi:10.1038/oby.2011.195
   PubMed Web of Science ®Google Scholar
• Orgel E, Tucci J, Alhushki W, et al. Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia. Blood. 2014;124(26):3932–3938. doi:10.1182/blood-2014-08-59538925349177
   PubMed Web of Science ®Google Scholar
• Aldhafiri FK, McColl JH, Reilly JJ. Prognostic significance of being overweight and obese at diagnosis in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2014;36(3):234–236. doi:10.1097/MPH.000000000000005624276040
   PubMed Web of Science ®Google Scholar
• den Hoed MA, Pluijm SMF, de Groot-kruseman HA, et al. The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia. Haematologica. 2015;100(1):62–69. doi:10.3324/haematol.2014.11066825304613
   PubMed Web of Science ®Google Scholar
• Eissa HM, Zhou Y, Panetta JC, et al. The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia. Blood Cancer J. 2017;7(2):e531. doi:10.1038/bcj.2017.1128212374
   PubMed Web of Science ®Google Scholar
• Yazbeck N, Samia L, Saab R, Abboud MR, Solh H, Muwakkit S. Effect of malnutrition at diagnosis on clinical outcomes of children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2016;38(2):107–110. doi:10.1097/MPH.000000000000042826479995
   PubMed Web of Science ®Google Scholar
• Martín-Trejo JA, Núñez-Enríquez JC, Fajardo-Gutiérrez A, et al. Early mortality in children with acute lymphoblastic leukemia in a developing country: the role of malnutrition at diagnosis. A multicenter cohort MIGICCL study. Leuk Lymphoma. 2017;58(4):898–908. doi:10.1080/10428194.2016.121990427561220
   PubMed Web of Science ®Google Scholar
• Núñez-Enríquez JC, Gil-Hernández AE, Jiménez-Hernández E, et al. Overweight and obesity as predictors of early mortality in Mexican children with acute lymphoblastic leukemia: a multicenter cohort study. BMC Cancer. 2019;19(1):708. doi:10.1186/s12885-019-5878-831319816
   PubMed Web of Science ®Google Scholar
• Mogensen PR, Wolthers BO, Grell K, Schmiegelow K, Frandsen TL. Association between body mass index and pancreatitis in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2018;65(8):e27071. doi:10.1002/pbc.2707129667750
   PubMed Web of Science ®Google Scholar
• Chaber R, Latos-Grażyńska E, Ciebiera K, et al. Body Mass Index (BMI) and Infectious/Febrile Episodes in Children with Intermediate Risk Acute Lymphoblastic Leukemia (IR ALL). Nutr Cancer. 2019;71(4):701–707. doi:10.1080/01635581.2018.151679230407874
   PubMed Web of Science ®Google Scholar
• Meenan CK, Kelly JA, Wang L, Ritchey AK, Maurer SH. Obesity in pediatric patients with acute lymphoblastic leukemia increases the risk of adverse events during pre-maintenance chemotherapy. Pediatr Blood Cancer. 2019;66(2):e27515. doi:10.1002/pbc.2751530362242
   PubMed Web of Science ®Google Scholar
• Withycombe JS, Smith LM, Meza JL, et al. Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2015;62(3):434–439. doi:10.1002/pbc.2531625407299
   PubMed Web of Science ®Google Scholar
• Browne EK, Zhou Y, Chemaitilly W, et al. Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia. Cancer. 2018;124(21):4248–4259. doi:10.1002/cncr.3173630358906
   PubMed Web of Science ®Google Scholar
• Seki Y, Okamoto Y, Kodama Y, et al. Risk factors and the prevention of weight gain during induction chemotherapy in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2018;40(6):e334–e337. doi:10.1097/MPH.000000000000109829401101
   PubMed Web of Science ®Google Scholar
• Hill R, Hamby T, Bashore L, et al. Early nutrition intervention attenuates weight gain for pediatric acute lymphoblastic leukemia patients in maintenance therapy. J Pediatr Hematol Oncol. 2018;40(2):104–110. doi:10.1097/MPH.000000000000097529045268
   PubMed Web of Science ®Google Scholar
• Esbenshade AJ, Simmons JH, Koyama T, Koehler E, Whitlock JA, Friedman DL. Body mass index and blood pressure changes over the course of treatment of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011;56(3):372–378. doi:10.1002/pbc.2278220860019
   PubMed Web of Science ®Google Scholar
• Inaba H, Surprise HC, Pounds S, et al. Effect of body mass index on the outcome of children with acute myeloid leukemia. Cancer. 2012;118(23):5989–5996. doi:10.1002/cncr.2764022648558
   PubMed Web of Science ®Google Scholar
• Canner J, Alonzo TA, Franklin J, et al. Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children’s Oncology Group. Cancer. 2013;119(23):4162–4169. doi:10.1002/cncr.2834224104395
   PubMed Web of Science ®Google Scholar
• Chen S-H, Jaing T-H, Hung I-J, Yang C-P, Chang T-Y. High body mass index did not result in poor outcome in Taiwanese children with acute myeloid leukemia: a single-institution experience. Int J Hematol. 2015;102(1):48–52. doi:10.1007/s12185-015-1795-z25840772
   PubMed Web of Science ®Google Scholar
• DJA L, Abrahamsson J, Ha S-Y, et al. Effect of age and body weight on toxicity and survival in pediatric acute myeloid leukemia: results from NOPHO-AML 2004. Haematologica. 2016;101(11):1359–1367. doi:10.3324/haematol.2016.14617527470605
   PubMed Web of Science ®Google Scholar
• Løhmann DJA, Asdahl PH, Abrahamsson J, et al. Associations between pretherapeutic body mass index, outcome, and cytogenetic abnormalities in pediatric acute myeloid leukemia. Cancer Med. 2019;8(15):6634–6643. doi:10.1002/cam4.255431532076
   PubMed Web of Science ®Google Scholar
• Gleimer M, Li Y, Chang L, et al. Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes. Bone Marrow Transplant. 2015;50(3):402–410. doi:10.1038/bmt.2014.28025531283
   PubMed Web of Science ®Google Scholar
• Bulley S, Gassas A, Dupuis LL, et al. Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation. Br J Haematol. 2008;140(2):214–217. doi:10.1111/j.1365-2141.2007.06900.x18028482
   PubMed Web of Science ®Google Scholar
• Pine M, Wang L, Harrell FE, et al. The effect of obesity on outcome of unrelated cord blood transplant in children with malignant diseases. Bone Marrow Transplant. 2011;46(10):1309–1313. doi:10.1038/bmt.2010.31221151185
   PubMed Web of Science ®Google Scholar
• Hoffmeister PA, Storer BE, Macris PC, Carpenter PA, Baker KS. Relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant. 2013;19(7):1081–1086. doi:10.1016/j.bbmt.2013.04.01723623893
   PubMed Web of Science ®Google Scholar
• Aplenc R, Zhang M-J, Sung L, et al. Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation. Blood. 2014;123(22):3504–3511. doi:10.1182/blood-2013-03-49033424711663
   PubMed Web of Science ®Google Scholar
• Paviglianiti A, Dalle JH, Ayas M, et al. Low body mass index is associated with increased risk of acute GVHD after umbilical cord blood transplantation in children and young adults with acute leukemia: a study on behalf of Eurocord and the EBMT pediatric disease working party. Biol Blood Marrow Transplant. 2018;24(4):799–805. doi:10.1016/j.bbmt.2017.12.79029288817
   PubMed Web of Science ®Google Scholar